EmitBio™ Granted Biotech Patent Covering Light to Treat COVID-19 and other Diseases

Company Demonstrates How Light Can Expand Countermeasures for Coronaviruses in Peer-Reviewed Manuscript

DURHAM, N.C., Nov. 2, 2021 /PRNewswire/ — EmitBio, Inc., a biotechnology company at the intersection of light and life science, today announced the issuance of a new U.S. patent protecting the Company’s novel treatment of COVID-19 and the underlying proprietary technology. U.S. patent 11,147,984 strengthens EmitBio’s intellectual property portfolio and broadly covers oral devices using light to limit or eliminate a vast array of pathogens including SARS-CoV-2, the virus that causes COVID-19.